Olson J L, Heptinstall R H
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Lab Invest. 1988 Nov;59(5):564-78.
From the above discussion it is clear that many factors have been invoked in the pathogenesis of progressive glomerular injury. Those which are most important include increased PGC, coagulation, serum lipid abnormalities, and hypertrophy. Although many hemodynamic alterations have been identified, increased PGC was noted most constantly. Furthermore, the loss of autoregulatory capability which was observed in some models with progressive glomerulosclerosis usually resulted in increased PGC. Increased PGC has been associated with augmented dietary protein and is seen in the Munich-Wistar rat made diabetic. Such an increase in PGC could cause direct mechanical injury to endothelial and epithelial cells, as well as be responsible for increased mesangial traffic of macromolecules with the potential for stimulating cellular proliferation and mesangial matrix increase. Additional support for the importance of increased PGC is provided by the protective effect of decreasing PGC with CEI therapy and anemia, and by the enhanced autoregulatory capability in both the Milan and Okamoto hypertensive rats. The significance of coagulation factors is confirmed by the formation of platelet and fibrin thrombi in the development of the glomerular lesions. The sequence of glomerular injury suggests that endothelial damage occurs with subsequent formation of platelet aggregates as a response to this injury. Formation of platelet aggregates may be associated with the production of substances potentially injurious to the endothelial cells. Although blocking the appearance of such thrombi by administration of heparin or thromboxane synthetase inhibitor prevents glomerular injury, the blood pressure lowering effect of these agents complicates the interpretation of the studies. Serum lipid abnormalities are also important factors in the progression of nonimmunologic glomerular injury. Such abnormalities are observed with increased dietary phosphorus or lipid, in the obese Zucker rat, and in rats with diabetes mellitus. Reduction in serum cholesterol by administration of clofibric acid or mevinolin diminishes glomerular injury independent of alterations in glomerular hemodynamics. The possible link between increased serum lipids and augmentation of glomerular injury is at present indirect. The importance of hypertrophy as a contributing factor to the progression of nonimmunologic glomerular injury is suggested by several lines of evidence. Hypertrophy, with increase in glomerular size and caliber of capillary loops, may amplify the effect of increased PGC by further intensifying the tension and mechanical stress on all elements of the capillary wall.(ABSTRACT TRUNCATED AT 400 WORDS)
从上述讨论中可以清楚地看出,许多因素被认为与进行性肾小球损伤的发病机制有关。其中最重要的因素包括肾小球毛细血管压力升高(PGC)、凝血、血清脂质异常和肥大。虽然已经确定了许多血流动力学改变,但PGC升高最为常见。此外,在一些进行性肾小球硬化模型中观察到的自身调节能力丧失通常导致PGC升高。PGC升高与饮食中蛋白质增加有关,在患糖尿病的慕尼黑-威斯塔大鼠中也可见到。这种PGC升高可直接对内皮细胞和上皮细胞造成机械损伤,也可导致系膜大分子转运增加,有可能刺激细胞增殖和系膜基质增加。通过血管紧张素转换酶抑制剂(CEI)治疗和贫血降低PGC的保护作用,以及米兰和冈本高血压大鼠增强的自身调节能力,进一步支持了PGC升高的重要性。凝血因子的重要性在肾小球病变发展过程中血小板和纤维蛋白血栓的形成中得到证实。肾小球损伤的顺序表明,内皮损伤会随后形成血小板聚集体,作为对这种损伤的反应。血小板聚集体的形成可能与产生对内皮细胞有潜在损伤的物质有关。虽然通过给予肝素或血栓素合成酶抑制剂阻止此类血栓的出现可预防肾小球损伤,但这些药物的降压作用使研究结果的解释变得复杂。血清脂质异常也是非免疫性肾小球损伤进展的重要因素。在饮食中磷或脂质增加时、在肥胖的 Zucker 大鼠以及糖尿病大鼠中可观察到此类异常。通过给予氯贝丁酯或美伐他汀降低血清胆固醇可减轻肾小球损伤,而与肾小球血流动力学改变无关。目前,血清脂质升高与肾小球损伤加重之间的可能联系是间接的。几条证据表明肥大作为非免疫性肾小球损伤进展的一个促成因素很重要。肥大伴随着肾小球大小和毛细血管襻管径的增加,可能通过进一步加剧毛细血管壁所有成分上的张力和机械应力来放大PGC升高的影响。(摘要截选至400词)